Results 1 to 10 of about 52,947 (295)

A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder [PDF]

open access: yesFrontiers in Psychiatry, 2019
Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS).
Laura A. Potter   +18 more
doaj   +4 more sources

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder [PDF]

open access: yesFrontiers in Genetics, 2020
Sertraline is one among several selective serotonin reuptake inhibitors (SSRIs) that exhibited improvement of language development in Autism Spectrum Disorder (ASD); however, the molecular mechanism has not been elucidated.
Reem Rafik Alolaby   +8 more
doaj   +3 more sources

Protective effects of vitamin E against sertraline-induced oxidative stress on the reproductive system and expression of Bcl-2, Caspase-3 and Hsp70-2 genes in testicular tissue of mice [PDF]

open access: diamondمجله علمی دانشگاه علوم پزشکی کردستان, 2022
Background and Aim: Sertraline is an antidepressant drug and many controversial reports have been presented on the complications of sertraline on the reproductive system.
Hassan Morovvati   +2 more
doaj   +2 more sources

Sertraline and inflammatory markers in major depression: a systematic review and meta-analysis [PDF]

open access: yesAnnals of General Psychiatry
Background Increasing evidence suggests a link between major depressive disorder (MDD) and inflammatory pathways. Sertraline, a commonly used selective serotonin reuptake inhibitor (SSRI), may influence inflammatory cytokine levels.
ZiLiang Xie   +5 more
doaj   +2 more sources

Sertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids [PDF]

open access: goldTranslational Psychiatry
In addition to modulating serotonin transport, selective serotonin reuptake inhibitors (SSRIs) have multiple other mechanisms that may contribute to clinical effects, and some of these latter actions prompt repurposing of SSRIs for non-psychiatric ...
Yukitoshi Izumi   +4 more
doaj   +2 more sources

The PREDEP-SERT study protocol: A 6-month follow-up cohort study of predictors of effectiveness, tolerability and safety of sertraline for depression using Therapeutic Drug Monitoring. [PDF]

open access: yesPLoS ONE
Sertraline is a common first-line pharmacological treatment of Major Depressive Disorder (MDD). There is no established consensus nor clinical guidelines for personalized dose adjustments, which imply risks of toxicity and lack of efficacy.
Patricio Molero   +8 more
doaj   +2 more sources

Sertraline

open access: yesReactions Weekly, 2006
europepmc   +3 more sources

Adverse Drug Events on the Use of Sertraline in Clinical Studies: A Review

open access: yesJurnal Manajemen dan Pelayanan Farmasi, 2021
Major depressive disorder (MDD) and anxiety are known as a widespread public health problem treated with sertraline, a class of Selective Serotonin Reuptake Inhibitor (SSRI) drugs as first-line therapy.
Syahrul Hidayat, Irma M. Puspitasari
doaj   +1 more source

La2O3/Co3O4 nanocomposite modified screen printed electrode for voltammetric determination of sertraline [PDF]

open access: yesJournal of the Serbian Chemical Society, 2020
La2O3/Co3O4 nanocomposite was synthesized and then used for the modification of screen-printed electrode (SPE) prior to the electrochemical determination of sertraline. A significant increment in peak current response was observed and peak potential also
Mohammadi Sayed Zia   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy